Medicines on the FDA drug shortage list, with which forms and strengths are affected, who makes them and when supply is expected back.
240 medicines
-
Quinapril Hydrochloride/Hydrochlorothiazide In shortage Some forms unavailable 3 products · updated October 2, 2026
Cardiovascular
Product Availability Expected supply / notes Quinapril Hydrochloride And Hydrochlorothiazide, Tablet, 25 mg; 20 mg (NDC 65862-163-90)
Aurobindo Pharma USAUnavailable Discontinuation of the manufacture of the drug
In shortage · October 2, 2026Quinapril Hydrochloride And Hydrochlorothiazide, Tablet, 12.5 mg; 20 mg (NDC 65862-162-90)
Aurobindo Pharma USAUnavailable Discontinuation of the manufacture of the drug
In shortage · October 2, 2026Quinapril Hydrochloride And Hydrochlorothiazide, Tablet, 12.5 mg; 10 mg (NDC 65862-161-90)
Aurobindo Pharma USAUnavailable Discontinuation of the manufacture of the drug
In shortage · October 2, 2026 -
Bumetanide Resolved 12 products · updated September 30, 2026
Cardiovascular
Product Availability Expected supply / notes Bumetanide, Injection, 0.25 mg/1 mL (NDC 72205-102-07)
MSN Laboratories Private Limited—
Resolved · September 30, 2026Bumetanide, Injection, .25 mg/1 mL (NDC 65219-570-04)
Fresenius Kabi USA, LLC—
Resolved · September 30, 2026Bumetanide, Injection, .25 mg/1 mL (NDC 0641-6007-10)
Hikma Pharmaceuticals USA, Inc.—
Resolved · September 30, 2026Bumetanide, Injection, 0.25 mg/mL, 10 mL (NDC 72205-102-01)
MSN Laboratories Private Limited—
Resolved · September 30, 2026Bumetanide, Injection, 1 mg/4 mL (0.25 mg/mL) (NDC 83301-0080-2)
Mullan Pharmaceutical Inc.—
Resolved · September 30, 2026Bumetanide, Injection, .25 mg/1 mL (NDC 0641-6008-10)
Hikma Pharmaceuticals USA, Inc.—
Resolved · September 30, 2026Bumetanide, Injection, 0.25 mg/mL, 4mL (NDC 72205-101-01)
MSN Laboratories Private Limited—
Resolved · September 30, 2026Bumetanide, Injection, .25 mg/1 mL (NDC 65219-572-10)
Fresenius Kabi USA, LLC—
Resolved · September 30, 2026Bumetanide, Injection, 2.5 mg/10 mL (0.25 mg/mL) (NDC 83301-0081-2)
Mullan Pharmaceutical Inc.—
Resolved · September 30, 2026Bumetanide, Injection, 0.25 mg/1 mL (NDC 72205-101-07)
MSN Laboratories Private Limited—
Resolved · September 30, 2026Bumetanide, Injection, .25 mg/1 mL (NDC 25021-321-04)
Sagent Pharmaceuticals—
Resolved · September 30, 2026Bumetanide, Injection, .25 mg/1 mL (NDC 25021-321-10)
Sagent Pharmaceuticals—
Resolved · September 30, 2026 -
Cromolyn Sodium Concentrate In shortage Limited supply 2 products · updated September 30, 2026
Pulmonary/Allergy
Product Availability Expected supply / notes Cromolyn Sodium, Concentrate, 100 mg/5 mL (NDC 69784-200-96)
Ailex PharmaceuticalsLimited No longer manufactured, some supplies still available in supply chain. Distributed by Woodward Pharma Services LLC (248) 308-1120 Ext 2
In shortage · September 30, 2026Cromolyn Sodium, Concentrate, 100 mg/5 mL (NDC 76204-025-96)
Ailex PharmaceuticalsLimited No longer manufactured, some supplies still available in supply chain. Distributed by Ritedose Pharmaceuticals, LLC (855) 806 3300
In shortage · September 30, 2026 -
Ivermectin Being discontinued 1 product · updated September 29, 2026
Anti-Infective
Product Availability Expected supply / notes STROMECTOL, Tablet, 3 mg (NDC 0006-0032-01)
Merck Sharp & Dohme LLCProduct will be discontinued on 10/31/2026
Being discontinued · September 29, 2026 -
Arsenic Trioxide Being discontinued 2 products · updated September 21, 2026
Oncology
Product Availability Expected supply / notes Arsenic Trioxide, Injection, 1 mg/1 mL (NDC 63323-637-10)
Fresenius Kabi USA, LLCDiscontinuation of the manufacture of the drug
Being discontinued · September 21, 2026Arsenic Trioxide, Injection, 1 mg/1 mL (NDC 50742-438-10)
Ingenus Pharmaceuticals LLCA business decision was made to discontinue manufacture of the drug.
Being discontinued · February 24, 2026 -
Rivaroxaban Being discontinued 1 product · updated September 18, 2026
Hematology
Product Availability Expected supply / notes Xarelto, For Suspension, 155 mg (NDC 50458-575-01)
Janssen PharmaceuticalsBusiness Decision
Being discontinued · September 18, 2026 -
Rivastigmine Being discontinued 1 product · updated September 18, 2026
Neurology
Product Availability Expected supply / notes Rivastigmine, Film, Extended Release, 4.6 mg/24 h (NDC 0378-9070-93)
Mylan Pharmaceuticals Inc., a Viatris CompanyDiscontinuation of the manufacture of the drug.
Being discontinued · September 18, 2026 -
Melphalan Hydrochloride Being discontinued 1 product · updated September 16, 2026
Oncology
Product Availability Expected supply / notes Melphalan Hydrochloride, Injection, Kit (NDC 63323-760-20)
Fresenius Kabi USA, LLCDiscontinuation of the manufacture of the drug
Being discontinued · September 16, 2026 -
Mesalamine Being discontinued 3 products · updated September 16, 2026
Gastroenterology
Product Availability Expected supply / notes Pentasa, Capsule, Extended Release, 250 mg (NDC 54092-189-81)
Takeda Pharmaceuticals USA Inc.Product is anticipated to be available until December 31, 2027
Being discontinued · September 16, 2026Pentasa, Capsule, Extended Release, 500 mg (NDC 54092-191-12)
Takeda Pharmaceuticals USA Inc.Product is anticipated to be available until December 31, 2027
Being discontinued · September 16, 2026Mesalamine, Capsule, Extended Release, .375 g (NDC 0378-1375-78)
Mylan Pharmaceuticals Inc., a Viatris CompanyDiscontinuation of the manufacture of the drug
Being discontinued · August 25, 2026 -
Flurazepam Hydrochloride In shortage Some forms unavailable 6 products · updated September 15, 2026
Oncology, Other, Neurology
Product Availability Expected supply / notes Flurazepam Hydrochloride, Capsule, 30 mg (NDC 0378-4430-01)
Rising Pharma Holdings, Inc.Unavailable Anticipated availability: Q4 2026; Delay is due to manufacturing delays at the contract manufacturing facility.
In shortage · September 1, 2026Flurazepam Hydrochloride, Capsule, 15 mg (NDC 0378-4415-01)
Rising Pharma Holdings, Inc.Unavailable Anticipated availability: Q4 2026; Delay is due to manufacturing delays at the contract manufacturing facility.
In shortage · September 1, 2026+ 4 more products listed, currently available.
-
Penicillin G Benzathin In shortage 1 product · updated September 15, 2026
Anti-Infective
Product Availability Expected supply / notes Lentocilin, Injection, 1200000 U/4 mL (NDC 84383-110-01)
Laboratorios AtralAvailable —
In shortage · September 15, 2026 -
Rocuronium In shortage Limited supply 2 products · updated September 15, 2026
Anesthesia
Product Availability Expected supply / notes Rocuronium Bromide, Injection, 100 mg/10 mL (NDC 66794-229-41)
Piramal Critical Care Inc.Limited On allocation
In shortage · September 15, 2026+ 1 more product listed, currently available.
-
Triamcinolone Hexacetonide In shortage 1 product · updated September 15, 2026
Rheumatology
Product Availability Expected supply / notes Hexatrione, Injection, 40 mg/2 mL (NDC 59137-570-01)
MedexusAvailable —
In shortage · September 15, 2026 -
Cisatracurium Besylate Being discontinued 3 products · updated September 11, 2026
Analgesia/Addiction
Product Availability Expected supply / notes Cisatracurium Besylate, Injection, 10 mg/5ml (2 mg/mL) Single Dose Vial (NDC 0409-1098-02)
Hospira, Inc., a Pfizer CompanySupply expected to exhaust November 2026; Discontinuation of the manufacture of the drug
Being discontinued · September 11, 2026Cisatracurium Besylate, Injection, 20 mg/10 mL (2 mg/mL) Multidose Vial (NDC 0409-1208-01)
Hospira, Inc., a Pfizer CompanySupply expected to exhaust late June 2026; Discontinuation of the manufacture of the drug
Being discontinued · May 6, 2026Cisatracurium Besylate, Injection, 200 mg/20ml (10 mg/mL) Single Dose Vial (NDC 0409-1103-01)
Hospira, Inc., a Pfizer CompanySupply expected to exhaust late June 2026; Discontinuation of the manufacture of the drug
Being discontinued · May 6, 2026 -
Micafungin Sodium Being discontinued 2 products · updated September 11, 2026
Anti-Infective
Product Availability Expected supply / notes Micafungin Sodium, Injection, 10 mg/1 mL (NDC 42023-229-10)
Par Health, USA LLCA business decision was made to discontinue manufacture of the drug.
Being discontinued · September 11, 2026Micafungin Sodium, Injection, 20 mg/1 mL (NDC 42023-230-10)
Par Health, USA LLCA business decision was made to discontinue manufacture of the drug.
Being discontinued · September 11, 2026 -
Dextrose Monohydrate, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride Being discontinued 1 product · updated September 10, 2026
Renal
Product Availability Expected supply / notes DELFLEX, Solution, 18.4 mg/100 mL; 4.25 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448 mg/100 mL (NDC 46163-212-95)
Fresenius Medical Care North AmericaA business decision was made to discontinue manufacture of the drug.
Being discontinued · September 10, 2026 -
Imipenem Anhydrous, Cilastatin, and Relebactam Anhydrous Being discontinued 1 product · updated September 9, 2026
Anti-Infective
Product Availability Expected supply / notes RECARBRIO, Injection, 500 mg/100 mL; 500 mg/100 mL; 250 mg/100 mL (NDC 0006-3856-02)
Merck Sharp & Dohme LLCTo be discontinued on or near late September 2026.
Being discontinued · September 9, 2026 -
Ifosfamide For In shortage 1 product · updated September 8, 2026
Oncology, Pediatric
Product Availability Expected supply / notes Ifosfamide, Injection, 1 g/1 (NDC 21586-211-02)
SteriMax, Inc.Available To place an order, please contact GlobalRX at info@globalrx.com or (919) 245-8418
In shortage · September 8, 2026 -
Echothiophate Iodide For In shortage 1 product · updated September 1, 2026
Ophthalmology
Product Availability Expected supply / notes Phospholine Iodide, Ophthalmic Solution, 0.125% (NDC 48102-053-05)
Fera PharmaceuticalsAvailable Available through limited distribution by Walgreens Specialty Pharmacy.
In shortage · September 1, 2026 -
Glycerol Phenylbutyrate Being discontinued 2 products · updated September 1, 2026
Inborn Errors
Product Availability Expected supply / notes RAVICTI, Oral Liquid, 1.1 g/1 mL (NDC 75987-050-06)
Amgen Inc.Discontinuation in the manufacturing of the drug product
Being discontinued · September 1, 2026RAVICTI, Oral Liquid, 1.1 g/1 mL (NDC 75987-050-07)
Amgen Inc.Discontinuation in the manufacturing of the drug product
Being discontinued · September 1, 2026 -
Insulin Glargine Being discontinued 1 product · updated September 1, 2026
Endocrinology/Metabolism
Product Availability Expected supply / notes Rezvoglar, Injection, 100 [iU]/1 mL (NDC 0002-8980-05)
Eli Lilly and Co.A business decision was made to discontinue manufacture of the drug. Distribution projected to end June 2027. If patients or prescribers have any questions, the Lilly Answers Center (1-800-545-5979) is available Monday through Friday from 9am to 8pm for assistance.
Being discontinued · September 1, 2026 -
Insulin Lispro Being discontinued 2 products · updated September 1, 2026
Endocrinology/Metabolism
Product Availability Expected supply / notes Insulin Lispro Junior KwikPen, Injection, 100 [iU]/1 mL (NDC 0002-7752-05)
Eli Lilly and Co.A business decision was made to discontinue manufacture of the drug. Distribution projected to end June 2027. If patients or prescribers have any questions, the Lilly Answers Center (1-800-545-5979) is available Monday through Friday from 9am to 8pm for assistance.
Being discontinued · September 1, 2026Humalog Mix 75/25, Injection, 100 [iU]/1 mL (NDC 0002-8233-05)
Eli Lilly and Co.A business decision was made to discontinue manufacture of the drug. Distribution projected to end June 2027. If patients or prescribers have any questions, the Lilly Answers Center (1-800-545-5979) is available Monday through Friday from 9am to 8pm for assistance.
Being discontinued · September 1, 2026 -
Medroxyprogesterone Acetate Being discontinued 2 products · updated August 31, 2026
Urology
Product Availability Expected supply / notes PROVERA, Tablet, 2.5 mg (NDC 0009-0065-01)
Pfizer Inc.Discontinuation of the manufacture of the drug; Withdrawal from sale expected early October 2026.
Being discontinued · August 31, 2026PROVERA, Tablet, 10 mg (NDC 0009-0051-01)
Pfizer Inc.Discontinuation of the manufacture of the drug; Withdrawal from sale expected September 2026.
Being discontinued · August 31, 2026 -
Metoprolol Succinate Being discontinued 7 products · updated August 31, 2026
Cardiovascular
Product Availability Expected supply / notes Metoprolol Succinate, Tablet, Extended Release, 50 mg (NDC 45963-676-11)
Teva Pharmaceuticals USA, Inc.A business decision was made to discontinue manufacture of the drug.
Being discontinued · August 31, 2026Metoprolol Succinate, Tablet, Extended Release, 100 mg (NDC 45963-677-11)
Teva Pharmaceuticals USA, Inc.A business decision was made to discontinue manufacture of the drug.
Being discontinued · August 31, 2026Metoprolol Succinate, Tablet, Extended Release, 200 mg (NDC 45963-678-11)
Teva Pharmaceuticals USA, Inc.A business decision was made to discontinue manufacture of the drug.
Being discontinued · August 31, 2026Metoprolol Succinate, Tablet, Extended Release, 50 mg (NDC 45963-676-96)
Teva Pharmaceuticals USA, Inc.A business decision was made to discontinue manufacture of the drug.
Being discontinued · August 31, 2026Metoprolol Succinate, Tablet, Extended Release, 100 mg (NDC 45963-677-96)
Teva Pharmaceuticals USA, Inc.A business decision was made to discontinue manufacture of the drug.
Being discontinued · August 31, 2026Metoprolol Succinate, Tablet, Extended Release, 25 mg (NDC 45963-709-96)
Teva Pharmaceuticals USA, Inc.A business decision was made to discontinue manufacture of the drug.
Being discontinued · August 31, 2026Metoprolol Succinate, Tablet, Extended Release, 25 mg (NDC 45963-709-11)
Teva Pharmaceuticals USA, Inc.A business decision was made to discontinue manufacture of the drug.
Being discontinued · August 31, 2026 -
Palovarotene Being discontinued 1 product · updated August 31, 2026
Musculoskeletal
Product Availability Expected supply / notes SOHONOS, Capsule, 2.5 mg (NDC 15054-0025-1)
Ipsen Biopharmaceuticals, Inc.Discontinuation of the manufacture of the drug
Being discontinued · August 31, 2026 -
Potassium Chloride Being discontinued 5 products · updated August 31, 2026
Cardiovascular, Endocrinology/Metabolism, Gastroenterology
Product Availability Expected supply / notes Cardioplegic Solution, Injection, Solution, 17.6 mg/100 mL; 325.3 mg/100 mL; 119.3 mg/100 mL; 643 mg/100 mL (NDC 65219-258-10)
Fresenius Kabi USA, LLCDiscontinuation of the manufacture of the drug
Being discontinued · August 31, 2026Potassium Chloride, Tablet, Extended Release, 20 meq (NDC 62037-720-10)
Teva Pharmaceuticals USA, Inc.Discontinuation of the manufacture of the drug
Being discontinued · November 21, 2025Potassium Chloride, Tablet, Extended Release, 20 meq (NDC 62037-720-05)
Teva Pharmaceuticals USA, Inc.Discontinuation of the manufacture of the drug
Being discontinued · November 21, 2025Potassium Chloride, Tablet, Extended Release, 20 meq (NDC 62037-720-01)
Teva Pharmaceuticals USA, Inc.Discontinuation of the manufacture of the drug
Being discontinued · November 21, 2025Potassium Chloride, Tablet, Extended Release, 10 meq (NDC 62037-710-01)
Teva Pharmaceuticals USA, Inc.Discontinuation of the manufacture of the drug
Being discontinued · November 21, 2025 -
Albuterol Sulfate Resolved 3 products · updated August 27, 2026
Pediatric, Pulmonary/Allergy
Product Availability Expected supply / notes Albuterol Sulfate, Solution, 2.5 mg/.5 mL (NDC 64980-642-03)
Rising Pharma Holdings, Inc.—
Resolved · August 27, 2026Albuterol Sulfate, Solution, 2.5 mg/.5 mL (NDC 0487-9901-30)
Nephron Pharmaceuticals Corporation—
Resolved · August 27, 2026Albuterol Sulfate, Solution, 2.5 mg/.5 mL (NDC 76204-027-01)
Ritedose Pharmaceuticals, LLC—
Resolved · August 27, 2026 -
Hydralazine Hydrochloride In shortage 1 product · updated August 27, 2026
Cardiovascular
Product Availability Expected supply / notes Furosemide, Injection, 10 mg/mL, 2 mL (NDC 71288-205-03)
Meitheal Pharmaceuticals, Inc.Available Check wholesalers for inventory
In shortage · August 27, 2026 -
Peginterferon Alfa-2a Resolved 2 products · updated August 27, 2026
Antiviral
Product Availability Expected supply / notes Pegasys, Injection, 180 ug/.5 mL (NDC 82154-0451-4)
pharmaand GmbH (pharma&)—
Resolved · August 27, 2026Pegasys, Injection, 180 ug/1 mL (NDC 82154-0449-1)
pharmaand GmbH (pharma&)—
Resolved · August 27, 2026 -
Disopyramide Phosphate Being discontinued 2 products · updated August 24, 2026
Cardiovascular
Product Availability Expected supply / notes Norpace CR, Capsule, Extended Release, 100 mg (NDC 0025-2732-31)
Pfizer Inc.Discontinuation of the manufacture of the drug
Being discontinued · August 24, 2026Norpace CR, Capsule, Extended Release, 150 mg (NDC 0025-2742-31)
Pfizer Inc.Discontinuation of the manufacture of the drug
Being discontinued · August 24, 2026
Reading the list: a medicine stays on the FDA list while any of its products is short. "Available" next to a product means that particular strength or pack can currently be ordered. If your pharmacy cannot fill a prescription, ask the pharmacist or prescriber about another strength, form or an alternative — do not ration or stop a medicine on your own.
Source: FDA Drug Shortages Database, via openFDA. Updated here twice a day; last update October 31, 2026 14:40. openFDA data are not validated for clinical use — confirm with the FDA source or your pharmacist.